Guidance for national tuberculosis programmes on the management of tuberculosis in children

World Health Organization.

This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...

Antituberculosos/administración & dosificación, Tuberculosis/tratamiento farmacológico, Tuberculosis/prevención & control, Tuberculosis Resistente a Múltiples Medicamentos/prevención & control, Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Tuberculosis/diagnóstico, Quimioterapia Combinada

Texto completo

The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: Interim policy guidance

World Health Organization.

WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far...

Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Resultado del Tratamiento, Antituberculosos/uso terapéutico, Diarilquinolinas/uso terapéutico

Texto completo (enlace principal)     Texto completo (enlace alternativo)    

Guidelines for the programmatic management of drug-resistant tuberculosis – 2011 update

World Health Organization.

This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and extensi...

Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Tuberculosis Resistente a Múltiples Medicamentos/prevención & control, Antituberculosos/administración & dosificación, Infecciones por VIH/tratamiento farmacológico, Terapia Antirretroviral Altamente Activa

Texto completo

Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement

World Health Organization.

Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...

Tuberculosis Resistente a Múltiples Medicamentos, Antituberculosos, Pruebas de Sensibilidad Microbiana, Mycobacterium tuberculosis/aislamiento & purificación

Texto completo

Treatment of tuberculosis: guidelines, 4th edition

World Health Organization.

This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition. First, the recommendation to discontinue the regimen based on just 2 months of rifampicin (2HRZE...

Antituberculosos/administración & dosificación, Tuberculosis Pulmonar/tratamiento farmacológico, Programas Nacionales de Salud, Cooperación del Paciente, Antituberculosos/uso terapéutico

Texto completo

Management of MDR-TB: a field guide: a companion document to guidelines for programmatic management of drug-resistant tuberculosis: integrated management of adolescent and adult illness (‎IMAI)‎

World Health Organization.

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) increasingly occur in resource-constrained settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centres) will need t...

Tuberculosis/terapia, Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Antituberculosos/administración & dosificación, Terapia por Observación Directa/métodos, Prestación Integrada de Atención de Salud/organización & administración, Terapia Antirretroviral Altamente Activa

Texto completo

Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs

World Health Organization.

This document is intended to provide an interim policy framework for the laboratory component relevant to programmatic implementation of MDR-TB strategies....

Tecnología Farmacéutica, Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Antituberculosos/uso terapéutico

Texto completo